SPONSOR
Hopital Foch
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 3
Conditions studied: XerostomiaPancreas NeoplasmsIntubation ComplicationEscharLung Transplant RejectionLung Transplant FailureLung Transplant; ComplicationsLung Transplant Failure and RejectionMayer Rokitansky Kuster Hauser SyndromeMuscle-Invasive Bladder Carcinoma
Hopital Foch is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Xerostomia, Pancreas Neoplasms, Intubation Complication, Eschar.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hopital Foch
How many clinical trials has Hopital Foch sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Hopital Foch, of which 7 are actively recruiting participants. These trials cover conditions including Xerostomia, Pancreas Neoplasms, Intubation Complication. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hopital Foch research focus on?
Hopital Foch clinical trials span Xerostomia, Pancreas Neoplasms, Intubation Complication, Eschar, Lung Transplant Rejection, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hopital Foch clinical trial?
To participate in a Hopital Foch trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hopital Foch trials with current recruitment status updated daily.
Clinical Trials by Hopital Foch
NCT04222478
Recruiting
Interest of Auriculotherapy in the Treatment of Xerostomia
Xerostomia
NCT06757244 Phase 2
Recruiting
DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Pancreas Neoplasms
NCT06533436
Recruiting
Clinical and Economic Comparison of 2 Methods of Intubation Tube Fixation : AnchorFastTM Versus Current Cord Fixation
Intubation Complication
NCT04837339
Recruiting
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
Lung Transplant Rejection
NCT03689842
Recruiting
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
Mayer Rokitansky Kuster Hauser Syndrome
NCT06537960
Recruiting
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
Muscle-Invasive Bladder Carcinoma
NCT06294847 Phase 3
Recruiting
Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery
Retinal Detachment
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology